Publications by authors named "Pallavi Parab"

Claim this Profile
A
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial.
Sudeep Gupta, Nita Nair, Rohini W Hawaldar, Shalaka Joshi, Seema Gulia, Pallavi Parab

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients.
Khusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, Jaya Chitra Aadhi, Shwetali Pandey, Pallavi Parab

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer.
Rohan Chaubal, Elizabeth Talker, Jaya Chitra, Rasika Kadam, Nilesh Gardi, Pallavi Parab

Breast Cancer Res Treat· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer.
Kripa Bajaj, Sushmita Rath, Deep Vora, Pallavi Parab, Seema Gulia

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.
Minit Shah, Sushmita Rath, Seema Gulia, Prabhat Bhargava, Anbarasan Sekar, Pallavi Parab

JCO Glob Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours.
Arnab Ghosh, Rohan Chaubal, Chitrarpita Das, Pallavi Parab, Subrata Das

Commun Biol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer.
Nilesh Gardi, Rohan Chaubal, Pallavi Parab, Sunil Pachakar, Suyash Kulkarni

Cancer Res Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer.
Ramesh Butti, Prachi Kapse, Garima Bhadauriya, Suhail Ahmad, Rohan Chaubal, Pallavi Parab

Oncol Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
Sushmita Rath, Prahalad Elamarthi, Pallavi Parab, Seema Gulia, Ravindra Nandhana

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicentre Observational Study on Risk Factors for Breast Cancer.
Suvarna Khadilkar, Mounika Bopanna, Pallavi Parab, Seema Gulia, Sandhya Chhasatia

J Obstet Gynaecol India· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to V.G. Gupta et al and W. Zou et al.
Sudeep Gupta, Amita Maheshwari, Pallavi Parab

J Clin Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
Sudeep Gupta, Amita Maheshwari, Pallavi Parab, Umesh Mahantshetty, Rohini Hawaldar

J Clin Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis